PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Autorzy:
Escobar M; Gulf States Hemophilia and Thrombophilia Center, Houston, Texas, USA. Luck J; Orthopaedic Hemophilia Treatment Center, Los Angeles, California, USA. Averianov Y; City Research and Development Center for Diagnostics and Treatment of Patients with Abnormal Hemostasis, Kyiv, Ukraine. Ducore J; Hematology/Oncology Clinic, University of California at Davis, Sacramento, California, USA. FernándezMFL; Hemostasis and Thrombosis Unit, Teresa Herrera Hospital, A Coruña, Spain. Giermasz A; Division of Hematology/Oncology, University of California at Davis, Sacramento, California, USA. Hart DP; The Royal London Hospital Haemophilia Centre, Barts and The London School of Medicine and Dentistry, QMUL, London, UK. Journeycake J; Oklahoma Center for Bleeding and Clotting Disorders, Oklahoma City, Oklahoma, USA. Kessler C; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA. Leissinger C; Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, USA. Mahlangu J; Hemophilia Comprehensive Care Center, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa. Martinez LV; Dr. José Eleuterio González Monterrey University Hospital, Monterrey, Nuevo León, México. Miesbach W; Goethe University Hospital, Frankfurt, Germany. Mitha IH; Lakeview Hospital, Benoni, Gauteng, South Africa. Quon D; Orthopaedic Hemophilia Treatment Center, Los Angeles, California, USA. Reding MT; Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, Minnesota, USA. Schved JF; Haemophilia Treatment Centre, University Hospital Montpellier, Montpellier, France. Stasyshyn O; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine. Vilchevska KV; National Specialized Children's Hospital Okhmatdyt, Kyiv, Ukraine. Wang M; Hemophilia and Thrombosis Center, University of Colorado, Aurora, Colorado, USA. Windyga J; Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland. Alexander WA; Aoede Associates, Athens, Texas, USA. Al-Sabbagh A; LFB-USA, Inc., Framingham, Massachusetts, USA. Bonzo D; LFB-USA, Inc., Framingham, Massachusetts, USA. Mitchell IS; HEMA Biologics, LLC, Louisville, Kentucky, USA. Wilkinson TA; GLOVAL LLC, Broomfield, Colorado, USA. Hermans C; Cliniques Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
